At Neuronostics we are reimagining the way neurological conditions are diagnosed, treated, and monitored. We use the power of mathematical modelling to develop novel biomarkers that create faster paths to diagnosis and effective treatment. Our first clinical indication, BioEP is an entirely new digital biomarker of epilepsy BioEP uses background EEG data and mathematical modelling to predict the likelihood of seizures. Our BioEP risk score supports clinical diagnostic and prognostic decisions of epilepsy. Our vision is that digital biomarkers are used routinely in neurology centres around the world to create a more proactive and anticipatory model of care. This will revolutionise neurological healthcare and radically improve the lives of people at risk of or living with neurological conditions.